As long as the temporal dynamics of CRC-PDE cultures are recognised, the CRC-PDE methodology can be a useful tool to address clinical translational questions such as tumour heterogeneity and progression, as well as drug sensitivity. This evidence concerns the gene ALDH7A1 and colorectal carcinoma.